# Scaling Up a Diabetes Prevention Program in Geographically and Ethnoculturally Diverse Urban Regions of Canada: Protocol for a Hybrid Type 2 Implementation-Effectiveness Study

**Authors:** Katie Weatherson, Jessica E Bourne, Kaela Cranston, Kyra Braaten, Natalie Grieve, Joseph Kelly, Mary E Jung

PMC · DOI: 10.2196/80276 · JMIR Research Protocols · 2026-01-19

## TL;DR

This study aims to scale up a diabetes prevention program across diverse Canadian cities to reduce type 2 diabetes risk effectively and equitably.

## Contribution

The study introduces a nationwide, community-based approach to implement and evaluate a diabetes prevention program in diverse urban settings.

## Key findings

- SSBC has enrolled 722 participants, with 44.7% from non-Western or Eastern European backgrounds.
- The program is being implemented in 13 sites, with plans to expand to 26 sites by 2026.
- The study will assess the effectiveness, cost-effectiveness, and sustainability of SSBC over six years.

## Abstract

It is estimated that type 2 diabetes (T2D) impacts an estimated 5.3 million Canadians, despite the condition being largely preventable. Laboratory-based diabetes prevention programs (DPPs) have limited effectiveness when translated into community settings due to their low-quality delivery and inability to reach people in the community most in need. To date, no community-based DPPs have been implemented nationwide across Canada. Small Steps for Big Changes (SSBC) is a diet and physical activity counseling intervention that significantly reduces the risk of developing T2D and has been designed for feasible delivery by community-dwelling peers. To ensure maximum public health impact, SSBC must be optimally implemented, demonstrate effectiveness for diverse groups, and be sustainable over time.

This project aims to adapt SSBC and evaluate the implementation, effectiveness, and sustainability of SSBC in diverse urban communities across Canada.

A hybrid type 2 implementation-effectiveness study design using multiple and mixed methods will be used to evaluate the implementation and effectiveness of SSBC over 6 years in partnership with 11 regional Young Men’s Christian Associations across 8 provinces in Canada. Beginning in 2024, we will (1) adapt and implement SSBC in diverse urban cities across Canada; (2) examine the implementation (including implementation strategies), effectiveness, and cost-effectiveness of SSBC (2024-2028); and (3) determine the sustainability of SSBC at each delivery location (2028-2029). Data will be collected from SSBC clients, coaches, site leads, and senior leadership municipality partners. The project will be overseen by an advisory group and 3 committees focused on sex, gender, and inclusivity; program evaluation; and diabetes prevention engagement. This study has received ethical approval from the University of British Columbia Clinical Research Ethics Board (H23-01930).

Funding for this project began in October 2022, and Institutional Review Board approval was obtained in October 2023. Program implementation within each region is occurring in a phased approach, with partners beginning program delivery in one site (2024-2025) before expanding to any additional locations (2025-2027). Program enrollment occurs continuously during the implementation phase across all sites. From 2024-2025, a total of 13 delivery sites began program delivery, 722 participants have enrolled in the program, and 406 have begun the program (153/342, 44.7% non-Western or Eastern European; 80/345, 23.2% men or 82/347, 23.6% male). An additional 13 sites have confirmed they will launch the program in 2026.

This study will demonstrate that SSBC can be scaled up nationwide to effectively and equitably reduce the Canadian population-level risk of T2D. This work will determine best practice implementation determinants, outcomes, and strategies critical for sustaining DPP implementation across Canada and beyond. Project findings will be shared with municipality partners and will be copresented with partners and SSBC clients to community organizations, local interested parties, and academics.

ClinicalTrials.gov NCT06440395; https://clinicaltrials.gov/study/NCT06440395

DERR1-10.2196/80276

## Linked entities

- **Diseases:** type 2 diabetes (MONDO:0005148)

## Full-text entities

- **Genes:** DSPP (dentin sialophosphoprotein) [NCBI Gene 1834] {aka DFNA39, DGI1, DMP3, DPP, DSP}
- **Diseases:** SSBC (MESH:D018288), YMCA (MESH:C564101), ISF (MESH:D000081042), T2D (MESH:D003924), Diabetes (MESH:D003920), weight loss (MESH:D015431), prediabetes (MESH:D011236), REDCap (MESH:D014947), food insecurity (MESH:D005517)
- **Chemicals:** sugar (MESH:D000073893), 5D (-), carbohydrate (MESH:D002241)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12865348/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12865348/full.md

## References

98 references — full list in the complete paper: https://tomesphere.com/paper/PMC12865348/full.md

---
Source: https://tomesphere.com/paper/PMC12865348